InsiderTrades.com logo

OLMA Insider Trading

Insider Ownership Percentage: 16.36%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $23,208,672.41

Olema Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Olema Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Olema Pharmaceuticals Share Price & Price History

Current Price: $13.97
Price Change: ▼ Price Decrease of -0.11 (-0.78%)
As of 03/23/2026 05:00 PM ET

This chart shows the closing price history over time for OLMA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Olema Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/4/2026Shawnte MitchellInsiderSell25,000$24.25$606,250.00View SEC Filing Icon  
3/3/2026Shawnte MitchellInsiderSell15,000$23.01$345,150.00View SEC Filing Icon  
1/20/2026Cyrus HarmonDirectorSell10,000$26.88$268,800.00727,770View SEC Filing Icon  
1/15/2026William Charles KovacsInsiderSell100,000$28.73$2,873,000.00139,727View SEC Filing Icon  
1/14/2026Cyrus HarmonDirectorSell3,489$29.12$101,599.68737,770View SEC Filing Icon  
1/13/2026David C. MylesInsiderSell50,000$27.60$1,380,000.00542,761View SEC Filing Icon  
1/13/2026William Charles KovacsInsiderSell3,822$28.01$107,054.22239,727View SEC Filing Icon  
1/12/2026David C. MylesInsiderSell10,000$28.34$283,400.00144,846View SEC Filing Icon  
12/23/2025Naseem ZojwallaInsiderSell99,509$27.66$2,752,418.944,488View SEC Filing Icon  
12/22/2025Cyrus HarmonDirectorSell2,881$28.53$82,194.93741,259View SEC Filing Icon  
12/22/2025Naseem ZojwallaInsiderSell100,000$28.04$2,804,000.0053,997View SEC Filing Icon  
12/19/2025David C. MylesInsiderSell51,000$30.46$1,553,460.00551,881View SEC Filing Icon  
12/19/2025Ian T ClarkDirectorSell264,800$29.73$7,872,504.00View SEC Filing Icon  
12/19/2025Naseem ZojwallaInsiderSell70,000$28.20$1,974,000.00103,997View SEC Filing Icon  
9/18/2025Cyrus HarmonDirectorSell10,000$8.33$83,300.00744,140View SEC Filing Icon  
9/18/2025Cyrus HarmonDirectorSell3,086$8.32$25,675.52117,028View SEC Filing Icon  
9/16/2025Cyrus HarmonDirectorSell10,000$8.04$80,400.00754,140View SEC Filing Icon  
9/16/2025Cyrus HarmonDirectorSell1,914$8.08$15,465.12120,114View SEC Filing Icon  
1/8/2025Bain Capital Life Sciences InvMajor ShareholderBuy300,000$5.76$1,728,000.007,800,000View SEC Filing Icon  
12/17/2024G. Walmsley GrahamDirectorSell700,761$6.75$4,730,136.75View SEC Filing Icon  
12/10/2024Cyrus HarmonDirectorSell8,256$9.37$77,358.72772,277View SEC Filing Icon  
12/10/2024David C. MylesInsiderSell12,452$9.38$116,799.76611,947View SEC Filing Icon  
12/10/2024Sean BohenCEOSell52,328$9.37$490,313.36298,836View SEC Filing Icon  
8/1/2024Biocapital Advisors L ParadigmMajor ShareholderSell2,400,000$14.91$35,784,000.00783,118View SEC Filing Icon  
7/29/2024Cyrus HarmonDirectorSell4,066$15.58$63,348.28752,217View SEC Filing Icon  
7/11/2024Cyrus HarmonDirectorSell5,000$12.26$61,300.00756,283View SEC Filing Icon  
6/28/2024Cyrus HarmonDirectorSell20,000$10.77$215,400.00761,283View SEC Filing Icon  
6/3/2024Cyrus HarmonDirectorSell5,000$10.93$54,650.00786,283View SEC Filing Icon  
5/31/2024Cyrus HarmonDirectorSell15,000$9.41$141,150.00791,283View SEC Filing Icon  
5/6/2024Cyrus HarmonDirectorSell5,000$10.92$54,600.00806,283View SEC Filing Icon  
4/30/2024Cyrus HarmonDirectorSell15,000$9.51$142,650.00811,283View SEC Filing Icon  
3/28/2024Cyrus HarmonDirectorSell20,000$10.97$219,400.00826,283View SEC Filing Icon  
2/29/2024Cyrus HarmonDirectorSell25,000$12.41$310,250.00846,283View SEC Filing Icon  
1/31/2024Cyrus HarmonDirectorSell25,000$12.23$305,750.00876,283View SEC Filing Icon  
12/6/2023Biocapital Advisors L ParadigmMajor ShareholderBuy100,000$11.60$1,160,000.006,590,981View SEC Filing Icon  
12/5/2023G. Walmsley GrahamDirectorBuy131,870$14.19$1,871,235.301,800,000View SEC Filing Icon  
11/30/2023Cyrus HarmonDirectorSell25,000$12.57$314,250.00926,283View SEC Filing Icon  
11/21/2023Cyrus HarmonDirectorSell4,192$14.86$62,293.12955,272View SEC Filing Icon  
11/21/2023Naseem ZojwallaInsiderSell7,461$14.84$110,721.2437,759View SEC Filing Icon  
11/21/2023Sean BohenCEOSell29,293$14.88$435,879.84172,857View SEC Filing Icon  
11/8/2023David C. MylesInsiderSell200$17.61$3,522.00561,270View SEC Filing Icon  
11/3/2023David C. MylesInsiderSell541$17.51$9,472.91561,470View SEC Filing Icon  
11/2/2023Cyrus HarmonDirectorSell5,000$15.64$78,200.00943,714View SEC Filing Icon  
11/1/2023David C. MylesInsiderSell6,668$15.02$100,153.36565,343View SEC Filing Icon  
10/31/2023Cyrus HarmonDirectorSell25,000$12.05$301,250.00948,714View SEC Filing Icon  
9/29/2023Cyrus HarmonDirectorSell25,000$12.41$310,250.00973,714View SEC Filing Icon  
9/19/2023David C. MylesInsiderSell20,000$12.67$253,400.00572,011View SEC Filing Icon  
9/12/2023Bvf Partners L P/IlDirectorBuy1,505,932$9.84$14,818,370.884,688,954View SEC Filing Icon  
9/5/2023Cyrus HarmonDirectorSell10,000$11.62$116,200.00998,714View SEC Filing Icon  
8/31/2023Cyrus HarmonDirectorSell15,000$9.36$140,400.001,008,714View SEC Filing Icon  
6/8/2023Cyrus HarmonDirectorSell10,000$6.30$63,000.001,038,714View SEC Filing Icon  
6/5/2023Cyrus HarmonDirectorSell5,000$6.04$30,200.001,053,714View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Olema Pharmaceuticals (NASDAQ:OLMA)

91.78% of Olema Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OLMA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Olema Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/23/2026Virtu Financial LLC42,437$1.06M0.0%N/A0.062%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.155,732$3.89M0.0%+25.0%0.227%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC10,009$0.25M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/18/2026Vestal Point Capital LP1,650,000$41.25M1.4%N/A2.403%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC8,049$0.20M0.1%-71.3%0.012%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP220,971$5.52M0.0%+8.2%0.322%Search for SEC Filing on Google Icon
2/18/2026Perceptive Advisors LLC165,713$4.14M0.1%N/A0.241%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC498,490$12.46M0.0%+50.4%0.726%Search for SEC Filing on Google Icon
2/18/2026Ishara Investments LP30,000$0.75M0.9%N/A0.044%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC6,710,194$167.90M0.1%+87.1%9.773%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP26,207$0.66M0.0%N/A0.038%Search for SEC Filing on Google Icon
2/18/2026Catalio Capital Management LP267,058$6.68M1.2%N/A0.389%Search for SEC Filing on Google Icon
2/18/2026Cormorant Asset Management LP2,750,000$68.75M3.2%N/A4.005%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.167,308$4.18M0.0%-75.9%0.244%Search for SEC Filing on Google Icon
2/18/2026Bridgeway Capital Management LLC40,500$1.01M0.0%-42.1%0.059%Search for SEC Filing on Google Icon
2/18/2026ACT Capital Management LLC53,500$1.34M1.1%N/A0.078%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC81,399$2.04M0.1%+33.0%0.119%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC113,978$2.85M0.0%N/A0.166%Search for SEC Filing on Google Icon
2/17/2026Burkehill Global Management LP125,000$3.13M0.2%N/A0.182%Search for SEC Filing on Google Icon
2/17/2026PDT Partners LLC27,368$0.68M0.0%+78.9%0.040%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers10,500$0.26M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/17/2026Jain Global LLC30,160$0.75M0.0%N/A0.044%Search for SEC Filing on Google Icon
2/17/2026RA Capital Management L.P.2,600,000$65M0.7%N/A3.787%Search for SEC Filing on Google Icon
2/17/2026Bain Capital Life Sciences Investors LLC8,508,641$212.72M16.3%+24.3%12.392%Search for SEC Filing on Google Icon
2/17/2026Paradigm Biocapital Advisors LP7,544,172$188.60M4.8%+11.0%10.988%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP49,754$1.24M0.0%N/A0.072%Search for SEC Filing on Google Icon
2/17/2026Jump Financial LLC100,274$2.51M0.0%N/A0.146%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD1,096,035$27.40M0.0%+3,348.7%1.596%Search for SEC Filing on Google Icon
2/17/2026Rock Springs Capital Management LP98,240$2.46M0.1%N/A0.143%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.210,000$5.25M0.0%N/A0.306%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.4,735$0.12M0.0%-12.3%0.007%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board34,940$0.87M0.0%N/A0.051%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC64,484$1.61M0.0%N/A0.094%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP150,670$3.77M0.0%N/A0.219%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada6,700$0.17M0.0%-95.5%0.010%Search for SEC Filing on Google Icon
2/17/2026Polar Capital Holdings Plc1,380,450$34.51M0.1%N/A2.011%Search for SEC Filing on Google Icon
2/16/2026Squarepoint Ops LLC328,680$8.22M0.0%+2,232.6%0.479%Search for SEC Filing on Google Icon
2/16/2026Verition Fund Management LLC33,382$0.84M0.0%N/A0.049%Search for SEC Filing on Google Icon
2/16/2026Nicholas Investment Partners LP64,757$1.62M0.1%N/A0.094%Search for SEC Filing on Google Icon
2/16/2026First Turn Management LLC617,714$15.44M1.8%N/A0.900%Search for SEC Filing on Google Icon
2/16/2026Eventide Asset Management LLC569,000$14.23M0.2%N/A0.829%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP17,304$0.43M0.0%N/A0.025%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC133,125$3.33M0.0%+27.2%0.194%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP360,394$9.01M0.0%N/A0.525%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 102,322$2.56M0.0%+398.1%0.149%Search for SEC Filing on Google Icon
2/13/2026Quarry LP3,001$75K0.0%-84.0%0.004%Search for SEC Filing on Google Icon
2/13/2026Vivo Capital LLC671,843$16.80M1.1%-55.4%0.979%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC45,005$1.13M0.0%N/A0.066%Search for SEC Filing on Google Icon
2/13/2026Birchview Capital LP269,000$6.73M3.9%+54.6%0.392%Search for SEC Filing on Google Icon
2/13/2026Siren L.L.C.3,300,700$82.52M2.5%N/A4.807%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.407,141$10.18M0.0%+3.0%0.593%Search for SEC Filing on Google Icon
2/13/2026State Street Corp1,884,399$47.11M0.0%+72.3%2.745%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN84,130$2.10M0.0%+84.2%0.123%Search for SEC Filing on Google Icon
2/13/2026Wealthspire Advisors LLC10,172$0.25M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/12/2026Empire Financial Management Company LLC25,000$0.63M0.1%N/A0.036%Search for SEC Filing on Google Icon
2/12/2026HRT Financial LP40,266$1.01M0.0%+147.2%0.059%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC33,500$0.84M0.0%-11.0%0.049%Search for SEC Filing on Google Icon
2/12/2026State Board of Administration of Florida Retirement System8,880$0.22M0.0%N/A0.013%Search for SEC Filing on Google Icon
2/12/2026Renaissance Technologies LLC25,067$0.63M0.0%-72.2%0.037%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP958,644$23.97M0.0%-9.9%1.396%Search for SEC Filing on Google Icon
2/12/2026Skandinaviska Enskilda Banken AB publ 281,687$7.04M0.0%N/A0.410%Search for SEC Filing on Google Icon
2/12/2026New York State Common Retirement Fund28,234$0.71M0.0%+218.4%0.041%Search for SEC Filing on Google Icon
2/12/2026Campbell & CO Investment Adviser LLC35,556$0.89M0.0%+22.4%0.052%Search for SEC Filing on Google Icon
2/12/2026Alps Advisors Inc.64,592$1.62M0.0%+98.7%0.094%Search for SEC Filing on Google Icon
2/12/2026Polen Capital Management LLC15,206$0.38M0.0%N/A0.022%Search for SEC Filing on Google Icon
2/12/2026Nuveen LLC229,469$5.74M0.0%+79.0%0.334%Search for SEC Filing on Google Icon
2/11/2026Deutsche Bank AG63,067$1.58M0.0%+3.2%0.092%Search for SEC Filing on Google Icon
2/11/2026LPL Financial LLC56,195$1.41M0.0%-41.9%0.082%Search for SEC Filing on Google Icon
2/11/2026Franklin Resources Inc.2,476,665$61.92M0.0%-17.8%3.607%Search for SEC Filing on Google Icon
2/11/2026JPMorgan Chase & Co.268,471$6.71M0.0%+791.0%0.391%Search for SEC Filing on Google Icon
2/11/2026Los Angeles Capital Management LLC38,078$0.95M0.0%N/A0.055%Search for SEC Filing on Google Icon
2/11/2026State of Wyoming4,676$0.12M0.0%-11.4%0.007%Search for SEC Filing on Google Icon
2/10/2026TD Asset Management Inc136,400$3.41M0.0%N/A0.199%Search for SEC Filing on Google Icon
2/10/2026Goldman Sachs Group Inc.817,889$20.45M0.0%+1.7%1.191%Search for SEC Filing on Google Icon
2/10/2026AXQ Capital LP21,323$0.53M0.1%N/A0.031%Search for SEC Filing on Google Icon
2/10/2026Intech Investment Management LLC25,198$0.63M0.0%+85.7%0.037%Search for SEC Filing on Google Icon
2/9/2026Geode Capital Management LLC1,257,441$31.44M0.0%-1.5%1.831%Search for SEC Filing on Google Icon
2/9/2026Swedbank AB55,100$1.38M0.0%N/A0.080%Search for SEC Filing on Google Icon
2/9/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.3,500$88K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/6/2026EverSource Wealth Advisors LLC1,245$31K0.0%+9,476.9%0.002%Search for SEC Filing on Google Icon
2/6/2026Legato Capital Management LLC11,554$0.29M0.0%N/A0.017%Search for SEC Filing on Google Icon
2/6/2026PSP Research LLC19,063$0.48M0.4%N/A0.028%Search for SEC Filing on Google Icon
2/6/2026Fideuram Intesa Sanpaolo Private Banking S.P.A.3,500$88K0.0%N/A0.005%Search for SEC Filing on Google Icon
2/6/2026ProShare Advisors LLC14,367$0.36M0.0%+13.8%0.021%Search for SEC Filing on Google Icon
2/3/2026Pier Capital LLC140,101$3.50M0.6%-73.3%0.204%Search for SEC Filing on Google Icon
2/3/2026Swedbank AB55,100$1.38M0.0%N/A0.080%Search for SEC Filing on Google Icon
2/2/2026Strs Ohio10,500$0.26M0.0%N/A0.015%Search for SEC Filing on Google Icon
2/2/2026Oppenheimer & Co. Inc.9,500$0.24M0.0%N/A0.014%Search for SEC Filing on Google Icon
1/30/2026Jennison Associates LLC963,997$24.10M0.0%N/A1.404%Search for SEC Filing on Google Icon
1/30/2026Torren Management LLC1,759$44K0.0%N/A0.003%Search for SEC Filing on Google Icon
1/29/2026Pictet Asset Management Holding SA502,568$12.60M0.0%-69.3%0.732%Search for SEC Filing on Google Icon
1/29/2026Inscription Capital LLC15,273$0.38M0.0%N/A0.022%Search for SEC Filing on Google Icon
1/29/2026Huntleigh Advisors Inc.20,130$0.50M0.1%N/A0.029%Search for SEC Filing on Google Icon
1/29/2026UBS Group AG293,560$7.34M0.0%-75.3%0.428%Search for SEC Filing on Google Icon
1/29/2026Vanguard Group Inc.3,561,355$89.03M0.0%+11.4%5.187%Search for SEC Filing on Google Icon
1/29/2026China Universal Asset Management Co. Ltd.13,018$0.33M0.0%+8.2%0.019%Search for SEC Filing on Google Icon
1/26/2026Mirae Asset Global Investments Co. Ltd.3,822$96K0.0%+44.1%0.006%Search for SEC Filing on Google Icon
1/16/2026Tema Etfs LLC44,505$1.11M0.1%N/A0.065%Search for SEC Filing on Google Icon
1/15/2026Nisa Investment Advisors LLC3,764$94K0.0%+14.5%0.005%Search for SEC Filing on Google Icon
1/14/2026Hennion & Walsh Asset Management Inc.447,046$11.18M0.4%+83.2%0.651%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Olema Pharmaceuticals logo
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 3 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer; and OP-1250 combine with CDK4/6 inhibitors palbociclib, ribociclib, and alpelisib in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive human epidermal growth factor receptor 2-negative breast cancer, as well as develops OPERA-01 for the of ER+/HER2- advanced or metastatic breast cancer. The company was formerly known as CombiThera, Inc. and changed its name to Olema Pharmaceuticals, Inc. in March 2009. Olema Pharmaceuticals, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Read More on Olema Pharmaceuticals

Today's Range

Now: $13.97
Low: $13.93
High: $14.91

50 Day Range

MA: $23.07
Low: $14.08
High: $29.19

52 Week Range

Now: $13.97
Low: $2.86
High: $36.26

Volume

1,414,177 shs

Average Volume

1,745,334 shs

Market Capitalization

$1.22 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.93

Who are the company insiders with the largest holdings of Olema Pharmaceuticals?

Olema Pharmaceuticals' top insider investors include:
  1. Bain Capital Life Sciences Inv (Major Shareholder)
  2. Cyrus Harmon (Director)
  3. Biocapital Advisors L Paradigm (Major Shareholder)
  4. David C Myles (Insider)
  5. Sean Bohen (CEO)
  6. Shane William Charles Kovacs (Insider)
  7. Naseem Zojwalla (Insider)
  8. G Walmsley Graham (Director)
  9. Ian T Clark (Director)
  10. Shawnte Mitchell (Insider)
Learn More about top insider investors at Olema Pharmaceuticals.

Who are the major institutional investors of Olema Pharmaceuticals?

Olema Pharmaceuticals' top institutional shareholders include:
  1. Bain Capital Life Sciences Investors LLC — 12.39%
  2. Paradigm Biocapital Advisors LP — 10.99%
  3. Janus Henderson Group PLC — 9.77%
  4. Vanguard Group Inc. — 5.19%
  5. Siren L.L.C. — 4.81%
  6. Cormorant Asset Management LP — 4.01%
Learn More about top institutional investors of Olema Pharmaceuticals stock.

Which major investors are selling Olema Pharmaceuticals stock?

During the previous quarter, OLMA stock was sold by these institutional investors:
  1. Pictet Asset Management Holding SA
  2. UBS Group AG
  3. Vivo Capital LLC
  4. Franklin Resources Inc.
  5. Balyasny Asset Management L.P.
  6. Pier Capital LLC
  7. Royal Bank of Canada
  8. Dimensional Fund Advisors LP
Within the last year, company insiders that have sold Olema Pharmaceuticals company stock include:
  1. Bain Capital Life Sciences Inv (Major Shareholder)
  2. Cyrus Harmon (Director)
  3. Biocapital Advisors L Paradigm (Major Shareholder)
  4. David C Myles (Insider)
  5. Sean Bohen (CEO)
  6. Shane William Charles Kovacs (Insider)
Learn More investors selling Olema Pharmaceuticals stock.

Which major investors are buying Olema Pharmaceuticals stock?

In the previous quarter, OLMA stock was acquired by institutional investors including:
  1. Siren L.L.C.
  2. Janus Henderson Group PLC
  3. Cormorant Asset Management LP
  4. RA Capital Management L.P.
  5. Bain Capital Life Sciences Investors LLC
  6. Vestal Point Capital LP
  7. Polar Capital Holdings Plc
  8. Price T Rowe Associates Inc. MD